AAAAAA

   
Results: 1-7 |
Results: 7
PHARMACOKINETICS AND BIOAVAILABILITY OF MONTELUKAST SODIUM (MK-0476) IN HEALTHY-YOUNG AND ELDERLY VOLUNTEERS
Authors: ZHAO JJ ROGERS JD HOLLAND SD LARSON P AMIN RD HAESEN R FREEMAN A SEIBERLING M MERZ M CHENG HY
Citation: Jj. Zhao et al., PHARMACOKINETICS AND BIOAVAILABILITY OF MONTELUKAST SODIUM (MK-0476) IN HEALTHY-YOUNG AND ELDERLY VOLUNTEERS, Biopharmaceutics & drug disposition, 18(9), 1997, pp. 769-777
METABOLIC PROFILES OF MONTELUKAST SODIUM (SINGULAR), A POTENT CYSTEINYL LEUKOTRIENE(1) RECEPTOR ANTAGONIST, IN HUMAN PLASMA AND BILE
Authors: BALANI SK XU X PRATHA V KOSS MA AMIN RD DUFRESNE C MILLER RR ARISON BH DOSS GA CHIBA M FREEMAN A HOLLAND SD SCHWARTZ JI LASSETER KC GERTZ BJ ISENBERG JI ROGERS JD LIN JH BAILLIE TA
Citation: Sk. Balani et al., METABOLIC PROFILES OF MONTELUKAST SODIUM (SINGULAR), A POTENT CYSTEINYL LEUKOTRIENE(1) RECEPTOR ANTAGONIST, IN HUMAN PLASMA AND BILE, Drug metabolism and disposition, 25(11), 1997, pp. 1282-1287
THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/
Authors: DAVIDSON MH STEIN EA DUJOVNE CA HUNNINGHAKE DB WEISS SR KNOPP RH ILLINGWORTH DR MITCHEL YB MELINO MR ZUPKIS RV DOBRINSKA MR AMIN RD TOBERT JA
Citation: Mh. Davidson et al., THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/, The American journal of cardiology, 79(1), 1997, pp. 38-42
DETERMINATION OF MK-0476 IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY
Authors: AMIN RD CHENG HY ROGERS JD
Citation: Rd. Amin et al., DETERMINATION OF MK-0476 IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 13(2), 1995, pp. 155-158
THE BIOAVAILABILITY AND NONLINEAR PHARMACOKINETICS OF MK-679 IN HUMANS
Authors: CHENG HY SCHWARTZ JI LIN C AMIN RD SEIBOLD JR LASSETER KC EBEL DL TOCCO DJ ROGERS JD
Citation: Hy. Cheng et al., THE BIOAVAILABILITY AND NONLINEAR PHARMACOKINETICS OF MK-679 IN HUMANS, Biopharmaceutics & drug disposition, 15(5), 1994, pp. 409-418
METABOLIC DISPOSITION OF SIMVASTATIN IN PATIENTS WITH T-TUBE DRAINAGE
Authors: CHENG HY SCHWARTZ MS VICKERS S GILBERT JD AMIN RD DEPUY B LIU L ROGERS JD POND SM DUNCAN CA OLAH TV BAYNE WF
Citation: Hy. Cheng et al., METABOLIC DISPOSITION OF SIMVASTATIN IN PATIENTS WITH T-TUBE DRAINAGE, Drug metabolism and disposition, 22(1), 1994, pp. 139-142
EVALUATION OF SUSTAINED CONTROLLED-RELEASE DOSAGE FORMS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A (HMG-COA) REDUCTASE INHIBITORS IN DOGS ANDHUMANS
Authors: CHENG HY SUTTON SC PIPKIN JD ZENTNER GM ROGERS JD SCHWARTZ JI MITCHEL YB GRASING K SCHWARTZ MS AMIN RD LIU L EBEL DL COULTER A ENGLE K MCCLELLAND GA LUI CY RORK GS
Citation: Hy. Cheng et al., EVALUATION OF SUSTAINED CONTROLLED-RELEASE DOSAGE FORMS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A (HMG-COA) REDUCTASE INHIBITORS IN DOGS ANDHUMANS, Pharmaceutical research, 10(11), 1993, pp. 1683-1687
Risultati: 1-7 |